|
|
 |
|
Viewing report
|
|
 |
 |
Canada Pharmaceuticals and Healthcare Report Q4 2008
Business Monitor International, Dec 2008, Pages: 74
Executive Summary 5 Canada Pharmaceuticals And Healthcare Industry SWOT 6 Canada Political SWOT 7 Canada Economic SWOT 7 Pharmaceutical Business Environment Ratings 8 Table: Americas Pharmaceutical Business Environment Rating 8 Limits Of Potential Returns 8 Risks To Realisation Of Returns 9 Canada – Market Summary 10 Regulatory Regime11 Pricing And Reimbursement Issues 14 Ontario Invests In Drug Industry 16 Industry Developments19 Product Approvals And Launches 24 Pharmaceutical Re-import Policy 26 Company Activity 27 National Pharmaceuticals Strategy 33 Generics Sector 34 Research And Development Sector 35 Pharmacy Sector 37 Industry Forecast Scenario 39 Overall Market Forecast 39 Table: Canadian Drug Market Indicators, 2005-2012 40 Key Growth Factors – Industry 40 Table: Canadian Health Expenditure Indicators, 2005-2012 41 Key Growth Factors – Macroeconomic 42 Table: Canada – Economic Activity 43 OTC Market Forecast 44 Table: Canadian OTC Drugs Market Indicators, 2006-2012 (US$mn unless otherwise stated) 45 Generics Market Forecast 46 Table: Canadian Generics Market Indicators, 2005-2012 47 Patented Market Forecast 48 Table: Canadian Patented Market Indicators, 2005-2012 48 Medical Device Market 49 Table: Canada’s Medical Device Market Forecast, 2004-2012 (US$mn unless otherwise stated) 50 Export/Import Forecasts 51 Table: Sectoral Trade Indicators, 2004-2012 (US$mn) 52 Other Healthcare Data Forecasts 52 Table: Canadian Socio-Demographic Indicators 52 Competitive Landscape53 Table: Canada’s Leading Generics Firms, 2006 53 Company Profiles54 Leading Multinational Manufacturers 54 Pfizer 54 Merck & Co 56 GlaxoSmithKline 58 Sanofi-Aventis 60 Novartis 62 Indigenous Manufacturers 63 Apotex 63 Country Snapshot: Canada Demographic Data66 Section 1: Population 66 Table: Demographic Indicators, 2005-2030 66 Table: Rural/Urban Breakdown, 2005-2030 67 Section 2: Education And Healthcare 67 Table: Education, 2000-2003 67 Table: Vital Statistics, 2005-2030 67 Section 3: Labour Market And Spending Power 68 Table: Employment Indicators, 2001-2006 68 Table: Consumer Expenditure, 2000-2012 (US$) 69 Table: Average Annual Manufactuing Wages, 2000-2012 69 BMI Forecast Modelling70 How We Generate Our Pharmaceutical Industry Forecasts 70 Pharmaceutical Business Environment Ratings Methodology 70 Ratings Overview 71 Table: Pharmaceutical Business Environment Indicators 72 Weighting 73 Table: Weighting Of Components 73 Sources 73
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Canada Pharmaceutical Industry
Generic Drug Market in Canada
Canada Pharmaceuticals and Healthcare Report Q2 2008
Canada Pharmaceuticals and Healthcare Report Q3 2008
Canada Pharmaceuticals and Healthcare Report Q3 2007
Canada Pharmaceuticals & Healthcare Report Q1 2008
The Pharmaceutical Market: Canada
Canada Pharmaceuticals and Healthcare Report Q2 2009
Pharmaceutical Pricing and Reimbursement in Canada
Canada Pharmaceuticals and Healthcare Report Q1 2009
Global Pharmaceutical Market Forecast to 2012
Executive Report on Strategies in Canada
|
 |
|
|